Results 331 to 340 of about 987,464 (392)

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

open access: yesMultiple Sclerosis Journal, 2018
Background: In the 2-year CLARITY study, cladribine tablets significantly improved clinical and magnetic resonance imaging (MRI) outcomes (vs placebo) in patients with relapsing–remitting multiple sclerosis (MS).
Gavin Giovannoni   +2 more
exaly   +2 more sources

Effect of geometry on drug release from 3D printed tablets

open access: yesInternational Journal of Pharmaceutics, 2015
Alvaro Goyanes Goyanes   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets

International Journal of Pharmaceutics, 2017
Jiaxiang Zhang, Xin Feng, Hemlata Patil
exaly   +2 more sources

3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets

open access: yesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
Alvaro Goyanes Goyanes   +2 more
exaly   +2 more sources

Ocular and visual discomfort associated with smartphones, tablets and computers: what we do and do not know

Clinical and experimental optometry, 2019
Smartphone and tablet use in Australia and worldwide is reaching saturation levels and associated visual and ocular discomfort such as headaches, eyestrain, dry eyes and sore eyes are widespread.
Sukanya Jaiswal   +5 more
semanticscholar   +1 more source

An Emerging Formulation Tablet in Tablet: An Overview

2023
In recent years, the Pharmaceutical industry has witnessed remarkable advancements in drug delivery technologies, a trend expected to continue. Among the various dosage forms, tablets remain one of the most preferred options due to their practicality, ease of administration, and patient compliance.
Sangeeta Saraswat   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy